272 related articles for article (PubMed ID: 33383780)
1. Biological Regulatory Network (BRN) Analysis and Molecular Docking Simulations to Probe the Modulation of IP
Ismatullah H; Jabeen I; Saeed MT
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383780
[TBL] [Abstract][Full Text] [Related]
2. Combined Pharmacophore and Grid-Independent Molecular Descriptors (GRIND) Analysis to Probe 3D Features of Inositol 1,4,5-Trisphosphate Receptor (IP
Ismatullah H; Jabeen I
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884798
[TBL] [Abstract][Full Text] [Related]
3. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 and IP
Ivanova H; Wagner LE; Tanimura A; Vandermarliere E; Luyten T; Welkenhuyzen K; Alzayady KJ; Wang L; Hamada K; Mikoshiba K; De Smedt H; Martens L; Yule DI; Parys JB; Bultynck G
Cell Mol Life Sci; 2019 Oct; 76(19):3843-3859. PubMed ID: 30989245
[TBL] [Abstract][Full Text] [Related]
5. Targeting Bcl-2-IP
Distelhorst CW
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
[TBL] [Abstract][Full Text] [Related]
6. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
[TBL] [Abstract][Full Text] [Related]
7. IP
Parys JB; Bultynck G; Vervliet T
Prog Mol Subcell Biol; 2021; 59():215-237. PubMed ID: 34050869
[TBL] [Abstract][Full Text] [Related]
8. Differential Regulation of Multiple Steps in Inositol 1,4,5-Trisphosphate Signaling by Protein Kinase C Shapes Hormone-stimulated Ca2+ Oscillations.
Bartlett PJ; Metzger W; Gaspers LD; Thomas AP
J Biol Chem; 2015 Jul; 290(30):18519-33. PubMed ID: 26078455
[TBL] [Abstract][Full Text] [Related]
9. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
Hedgepeth SC; Garcia MI; Wagner LE; Rodriguez AM; Chintapalli SV; Snyder RR; Hankins GD; Henderson BR; Brodie KM; Yule DI; van Rossum DB; Boehning D
J Biol Chem; 2015 Mar; 290(11):7304-13. PubMed ID: 25645916
[TBL] [Abstract][Full Text] [Related]
10. Analysis of IP3 receptors in and out of cells.
Rossi AM; Tovey SC; Rahman T; Prole DL; Taylor CW
Biochim Biophys Acta; 2012 Aug; 1820(8):1214-27. PubMed ID: 22033379
[TBL] [Abstract][Full Text] [Related]
11. Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. Coordinate signaling changes and differential suppression of cell growth and transformation.
Fischer GA; Clementi E; Raichman M; Südhof T; Ullrich A; Meldolesi J
J Biol Chem; 1994 Jul; 269(30):19216-24. PubMed ID: 8034682
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional insight into a new emerging target IP
Ismatullah H; Jabeen I; Kiani YS
J Biomol Struct Dyn; 2024; 42(4):2170-2196. PubMed ID: 37070253
[TBL] [Abstract][Full Text] [Related]
13. Remodeling of Ca
Ando H; Kawaai K; Bonneau B; Mikoshiba K
Adv Biol Regul; 2018 May; 68():64-76. PubMed ID: 29287955
[TBL] [Abstract][Full Text] [Related]
14. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2.
Akl H; Monaco G; La Rovere R; Welkenhuyzen K; Kiviluoto S; Vervliet T; Molgó J; Distelhorst CW; Missiaen L; Mikoshiba K; Parys JB; De Smedt H; Bultynck G
Cell Death Dis; 2013 May; 4(5):e632. PubMed ID: 23681227
[TBL] [Abstract][Full Text] [Related]
15. IP
Hamada K; Mikoshiba K
Annu Rev Physiol; 2020 Feb; 82():151-176. PubMed ID: 31730387
[TBL] [Abstract][Full Text] [Related]
16. Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4, 5-trisphosphate receptor by Ca2+ and calmodulin.
Sipma H; De Smet P; Sienaert I; Vanlingen S; Missiaen L; Parys JB; De Smedt H
J Biol Chem; 1999 Apr; 274(17):12157-62. PubMed ID: 10207043
[TBL] [Abstract][Full Text] [Related]
17. New Insights in the IP
Parys JB; Vervliet T
Adv Exp Med Biol; 2020; 1131():243-270. PubMed ID: 31646513
[TBL] [Abstract][Full Text] [Related]
18. IP
Roest G; La Rovere RM; Bultynck G; Parys JB
Adv Exp Med Biol; 2017; 981():149-178. PubMed ID: 29594861
[TBL] [Abstract][Full Text] [Related]
19. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.
Akl H; Bultynck G
Biochim Biophys Acta; 2013 Apr; 1835(2):180-93. PubMed ID: 23232185
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist.
Azumaya CM; Linton EA; Risener CJ; Nakagawa T; Karakas E
J Biol Chem; 2020 Feb; 295(6):1743-1753. PubMed ID: 31915246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
